1. Miri, Mahboobe, Hemati, Simin, Safari, Foruzan, Tavassoli, Manoochehr. 2011. GGCn polymorphism of eRF3a/GSPT1 gene and breast cancer susceptibility. In Medical oncology (Northwood, London, England), 29, 1581-5. doi:10.1007/s12032-011-0111-x. https://pubmed.ncbi.nlm.nih.gov/22101789/
2. Yang, Gang, Guan, Wenfang, Cao, Zhe, Zhao, Yupei, Gu, Jin. 2021. Integrative Genomic Analysis of Gemcitabine Resistance in Pancreatic Cancer by Patient-derived Xenograft Models. In Clinical cancer research : an official journal of the American Association for Cancer Research, 27, 3383-3396. doi:10.1158/1078-0432.CCR-19-3975. https://pubmed.ncbi.nlm.nih.gov/33674273/
3. Long, Xuan, Zhao, Lijun, Li, Guoqiang, Wang, Ziwei, Deng, Zhigang. 2021. Identification of GSPT1 as prognostic biomarker and promoter of malignant colon cancer cell phenotypes via the GSK-3β/CyclinD1 pathway. In Aging, 13, 10354-10368. doi:10.18632/aging.202796. https://pubmed.ncbi.nlm.nih.gov/33819920/
4. Li, Zheng, Xie, Xiaoxia, Fan, Xiangyun, Li, Xing. 2020. Long Non-coding RNA MINCR Regulates miR-876-5p/GSPT1 Axis to Aggravate Glioma Progression. In Neurochemical research, 45, 1690-1699. doi:10.1007/s11064-020-03029-8. https://pubmed.ncbi.nlm.nih.gov/32333234/
5. Ozawa, K, Murakami, Y, Eki, T, Ui, M, Hanaoka, F. . Mapping of the human GSPT1 gene, a human homolog of the yeast GST1 gene, to chromosomal band 16p13.1. In Somatic cell and molecular genetics, 18, 189-94. doi:. https://pubmed.ncbi.nlm.nih.gov/1574740/